EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)—Evident Corporation, a premier manufacturer of life...

CAMBRIDGE, Mass. & BERN, Switzerland--(BUSINESS WIRE)--Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University...

Ultivue announces new educational webinar series for the scientist looking for end-to-end biomarker strategy support. Register Now What if you had the knowledge to answer your questions about the tissue microenvironment all in one...

Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of...

PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...

Join us for a complimentary joint Visiopharm & Ultivue webinar! Advanced Phenotyping of the Tumor Immune Microenvironment MAY 26, 2021 | 9:00AM (PDT) | 12:00PM (EDT) | 6:00PM (CET) Register Now Immunotherapy has transformed the...